Detalhe da pesquisa
1.
Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma.
N Engl J Med
; 388(3): 228-239, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652354
2.
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
J Biomed Sci
; 31(1): 21, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350919
3.
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer.
Pancreatology
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565467
4.
The emergence of RAS mutations in patients with RAS wild-type mCRC receiving cetuximab as first-line treatment: a noninterventional, uncontrolled multicenter study.
Br J Cancer
; 129(6): 947-955, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488448
5.
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
BMC Cancer
; 23(1): 180, 2023 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814222
6.
Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer.
Future Oncol
; 19(34): 2277-2289, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746835
7.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(2): 234-247, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35030335
8.
Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness.
Cancer Sci
; 113(5): 1601-1612, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35253323
9.
A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study.
Br J Cancer
; 126(7): 1018-1026, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921230
10.
PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
J Biomed Sci
; 29(1): 92, 2022 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36336681
11.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480657
12.
Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.
Int J Med Sci
; 19(10): 1615-1627, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185333
13.
Incidence and survival variations of upper tract urothelial cancer in Taiwan (2001-2010).
Int J Urol
; 29(2): 121-127, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34708447
14.
Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation.
J Formos Med Assoc
; 121(1 Pt 1): 170-180, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707140
15.
Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/ß-Catenin/Cyclin D1 Pathway.
Int J Mol Sci
; 23(5)2022 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35269749
16.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34592180
17.
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Cancer Sci
; 112(1): 243-253, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128283
18.
A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
Oncologist
; 26(3): e367-e373, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140457
19.
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors.
Oncologist
; 26(4): e567-e579, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33245172
20.
AUY922 induces retinal toxicity through attenuating TRPM1.
J Biomed Sci
; 28(1): 55, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301262